GlobeNewswire
-
Merit Medical Reports First Quarter 2026 Results and Updates Full-Year Guidance
30/04/2026 -
Akebia Therapeutics to Report First Quarter 2026 Financial Results and Discuss Recent Business Highlights
30/04/2026 -
Echo IQ Announces EchoSolv AS Deployed into Mount Sinai Health System
30/04/2026 -
Century Therapeutics Selected for Oral Presentation of CNTY‑813 Preclinical Data at the American Diabetes Association 86th Scientific Sessions
30/04/2026 -
Axsome Therapeutics Announces FDA Approval of AUVELITY® (dextromethorphan HBr and bupropion HCl) for the Treatment of Agitation Associated with Dementia due to Alzheimer’s Disease
30/04/2026 -
TME Pharma publishes its annual financial results and annual report
30/04/2026 -
TME PHARMA PUBLIE SES RÉSULTATS FINANCIERS ANNUELS ET SON RAPPORT ANNUEL
30/04/2026 -
RAPPORT FINANCIER 2025
30/04/2026 -
Sofanya Launches Highly Anticipated Sacred Body Oil Just in Time for Mother's Day: 'this isn't about doing more, it's about coming back'
30/04/2026 -
Ocubio Announces Appointment of Jim Mazzo and Dr. Eric Donnenfeld as Strategic Advisors
30/04/2026 -
KAI Conversations Announces Strategic Partnership with Syneos Health to Advance U.S. Pharmaceutical Commercialization
30/04/2026 -
Spineway : First-quarter 2026 revenue
30/04/2026 -
SPINEWAY :
30/04/2026 -
Disclosure of transparency notification from BlackRock, Inc.
30/04/2026 -
MISE A DISPOSITION DU RAPPORT FINANCIER ANNUEL 2025
30/04/2026 -
MISE A DISPOSITION DU RAPPORT FINANCIER ANNUEL 2025
30/04/2026 -
Confo Therapeutics Announces Phase 2 Clinical Trial Initiation by Lilly for Peripheral Pain Candidate, CFTX-1554
30/04/2026 -
Zealand Pharma conference call on May 7 at 2pm CET (8am ET) to present first quarter 2026 financial results
30/04/2026 -
BioRestorative Therapies to Present New Data at ISCT 2026 Highlighting Its Ongoing Phase 2 Clinical Trial in Chronic Lumbar Disease and Its BioCosmeceutical Platform
30/04/2026
Pages